Prognostic Value of Serum Procalcitonin in Patients with Sepsis in a Tertiary Level Hospital

Authors

  • Aflatun Akter Jahan Specialist Internal Medicine, Square Hospital Ltd, Dhaka, Bangladesh
  • Md Raziur Rahman Prof and HOD, Department of Medicine, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh
  • Jamal Uddin Ahmed Associate Professor, Department of Medicine, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh
  • Sameena Khan Assistant Professor, Department of Microbiology, Dr. D Y Patil Medical College, Hospital &Research Center, Dr. D Y Patil Vidyapeeth, Pimpri, Pune -18

DOI:

https://doi.org/10.3329/jom.v24i1.64899

Keywords:

Sepsis, Procalcitonin, multi-organ failure

Abstract

Background: Sepsis is a complex, life-threatening, heterogeneous infectious disease associated with increased rates of morbidity and mortality. Early assessment of the prognosis of sepsis is key to achieving a favorable outcome for the disease. This study aimed to identify the prognostic value of PCT for sepsis patients.

Materials and Methods: We conducted a prospective analytical study involving 100 adult patients with sepsis who were admitted to the Medicine dept and intensive care unit from 2019 to 2020. At least one blood test for PCT level was performed for all patients within the first 24 hours of suspecting an infection.

Results: Our study found that a maximum number of patients (43.0%) were between 51-60 years age group, mean age of the patient was 49.35 ± 11.7 years. Out of 100 cases, 65% were male and 35% were female. The male and female ratio was 1.85:1. In this study serum, procalcitonin levels 0.5-2.0 ng/were detected in 15.0% of patients with mean±SD 1.3±0.8. Serum procalcitonin levels 2.1-10.0 ng/mL were detected in 29.0% of patients with mean±SD 5.9±2.5 and >10.0 ng/mL was detected in 56 patients. Based on the receiver-operator characteristic (ROC) curves, procalcitonin had the area under curve 0.923, with 89.4% sensitivity and 87.5% specificity. In our study, procalcitonin showed the best predictive value for the short-term outcome of sepsis with a cut-off value of 14.8 ng/mL (AUC 0.923). Study shows that 76.0% of the patients recovered completely, but 24.0% of patients expired during the hospital stay.

Conclusion: There was a statistically significant correlation in serum procalcitonin with the outcome of sepsis (p < 0.001). So the effectiveness of serum procalcitonin has proven significant in the prediction of mortality in sepsis patients.

J MEDICINE 2023; 24: 18-22

Downloads

Download data is not yet available.
Abstract
1
PDF
2

Downloads

Published

2023-03-22

How to Cite

Jahan, A. A. ., Rahman, M. R. ., Ahmed, J. U. ., & Khan, S. . (2023). Prognostic Value of Serum Procalcitonin in Patients with Sepsis in a Tertiary Level Hospital. Journal of Medicine, 24(1), 18–22. https://doi.org/10.3329/jom.v24i1.64899

Issue

Vol. 24 No. 1 (2023)

Section

Original Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).